CN Patent

CN110545813A — 包含阿托品的用于防止或延迟近视发作的组合物和方法

Assigned to Singapore Health Services Pte Ltd · Expires 2019-12-06 · 6y expired

What this patent protects

公开了通过使用包含小于0.025％阿托品的组合物防止或延迟前近视患者的近视发作的方法以及减少或防止低度近视患者的近视的进展的方法。

USPTO Abstract

公开了通过使用包含小于0.025％阿托品的组合物防止或延迟前近视患者的近视发作的方法以及减少或防止低度近视患者的近视的进展的方法。

Drugs covered by this patent

pilocarpine-hydrochloride (PILOCARPINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN110545813A
Jurisdiction: CN
Classification: —
Expires: 2019-12-06
Drug substance claim: No
Drug product claim: No
Assignee: Singapore Health Services Pte Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.